What happens when you combine an industry-altering, AI-powered platform with a leading CRO's preclinical expertise?  That’s what Valo Health and Charles River are answering with the introduction of Logica™. This revolutionary platform aims to accelerate drug discovery and development by finding the most viable molecules faster, helping biotechs and pharma focus their resources only on the ones that will evolve into therapies that patients will receive more quickly.   Join Guido Lanza (Valo) and Julie Frearson (Charles River) as they discuss the components of Logica™, what makes it unique from other platforms, and how it will transform the future of drug discovery.   Show Notes 

https://www.criver.com/products-services/discovery-services/logica-transformative-drug-design 

https://www.criver.com/insights/charles-river-and-valo-health-launch-logica 

https://www.criver.com/eureka/medicine-meet-ai-how-machine-learning-transforming-drug-discovery  

Valo Health Is Partnering With Charles River Laboratories To Accelerate Preclinical Drug Discovery  

Charles River, Valo Enter AI-enabled Drug Discovery Pact